2015 Pharma Companies Small Molecule 
The Pharma Data
SEPTEMBER 29, 2020
The collaboration has leveraged Sosei’s StaR technology and Structure-based Drug Design (SBDD) capabilities to design oral small molecules that modulate different G protein-coupled receptor (GPCR) targets across multiple disease areas.
Dark Matter Blog
JUNE 21, 2023
Since our company’s founding in 2015, we have taken the long view and been singularly focused on building an extremely flexible and broadly applicable platform that can develop a host of RNA‑targeted small molecules (rSMs) to deliver precision medicines for dozens of targets that have been out of reach for conventional approaches.
The Pharma Data
OCTOBER 14, 2020
Lanifibranor is believed to be the first drug candidate to be granted this status for the treatment of NASH since January 2015. Talking Medicine uses advanced AI to provide pharmaceutical companies with real-time data intelligence. Dolmatics – U.K.-based based Dotmatics Ltd.
Expert insights. Personalized for you.
52 
Let's personalize your content